Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Natera Inc    NTRA

NATERA INC (NTRA)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 11/17 10:00:00 pm
9.62 USD   -0.31%
11/09 NATERA : reports 3Q loss
11/08 NATERA : Reports Third Quarter 2017 Financial Results
11/02 NATERA : Announces Third Quarter 2017 Earnings Conference Call
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/13/2017 11/14/2017 11/15/2017 11/16/2017 11/17/2017 Date
9.34(c) 9.36(c) 9.4(c) 9.65(c) 9.62(c) Last
128 902 149 532 176 781 134 035 213 451 Volume
+1.63% +0.21% +0.43% +2.66% -0.31% Change
More quotes
Financials ($)
Sales 2017 214 M
EBIT 2017 -113 M
Net income 2017 -117 M
Finance 2017 14,3 M
Yield 2017 -
Sales 2018 254 M
EBIT 2018 -75,6 M
Net income 2018 -89,4 M
Debt 2018 24,6 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 2,35x
EV / Sales2018 2,13x
Capitalization 517 M
More Financials
Company
Natera, Inc. operates as a genetic testing company, which develops proprietary bioinformatics-based technology.It provides preconception and prenatal genetic testing services for in-vitro fertilization clinics to identify genetic diseases and chromosomal abnormalities in embryos prior to... 
More about the company
Surperformance© ratings of Natera Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on NATERA INC
11/16 NATERA : Selected for Circulating Tumor DNA Study in Colorectal Cancer
11/09 NATERA : Chosen for Longitudinal Circulating Tumor DNA Study in Breast Cancer
11/09 NATERA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
11/09 NATERA : reports 3Q loss
11/08 NATERA, INC. : Results of Operations and Financial Condition, Financial Statemen..
11/08 NATERA : Reports Third Quarter 2017 Financial Results
11/08 NATERA INC : Natera, Inc. to Host Earnings Call
11/03 NATERA : Chosen for Longitudinal Circulating Tumour DNA Study in Breast Cancer
11/02 NATERA : Announces Third Quarter 2017 Earnings Conference Call
10/05 NATERA : New Information Theory Data Have Been Reported by Researchers at Natera..
More news
Sector news : Diagnostic & Testing Substances
11/13 Poor earnings updates keep European shares at seven-week low
11/13 SONOVA : misses sales, profit forecasts as U.S. overhaul bites
11/12 FISHER & PAYKEL HEALTHCARE : & Paykel says UK court rules rival Resmed's patent ..
11/03 ESSILOR INTERNATIONAL : EU regulators suspend Luxottica, Essilor probe, await da..
11/03DJESSILOR INTERNATIONAL : EU Regulator Has Suspended Essilor, Luxottica Probe -Reu..
More sector news : Diagnostic & Testing Substances
News from SeekingAlpha
11/09 Natera's (NTRA) CEO Matthew Rabinowitz on Q3 2017 Results - Earnings Call Tra..
11/08 Natera 2017 Q3 - Results - Earnings Call Slides
11/08 Natera misses by $0.03, beats on revenue
11/07 Notable earnings after Wednesday?s close
08/09 Midday Gainers / Losers
Chart NATERA INC
Duration : Period :
Natera Inc Technical Analysis Chart | NTRA | US6323071042 | 4-Traders
Technical analysis trends NATERA INC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Average target price 15,8 $
Spread / Average Target 65%
EPS Revisions
Managers
NameTitle
Matthew Rabinowitz Chairman, President & Chief Executive Officer
Damon Silvestry Vice President-Operations
Mike Brophy CFO, Director & Head-Investor Relations
Jonathan Sheena Director & Chief Technology Officer
Michael C. Little Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
NATERA INC-17.85%517
BIOMERIEUX42.09%9 377
DIASORIN SPA31.56%4 949
AUTOBIO DIAGNOSTICS CO LTD-3.58%3 409
MACCURA BIOTECHNOLOGY CO LTD--.--%2 106
SIEGFRIED HOLDING AG41.08%1 295